Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Delta 9 Cannabis Inc DLTNF

Delta 9 Cannabis Inc. is a Canada-based vertically integrated cannabis company. The Company operates through three segments: Wholesale Cannabis, Retail Cannabis and Merchandise and Devices, and Business to Business. The Company sells cannabis products through its wholesale and retail sales channels and sells its cannabis growing pods to other businesses. Its cannabis products include dried cannabis and pre-rolled joints. Its edibles and vapes include vape pens and concentrates, edibles, and drinkables. The Company, through its wholly owned subsidiary, Delta 9 Bio-Tech Inc., is a licensed producer of medical and recreational cannabis products and operates a 95,000-square-foot Health Canada licensed production facility in Winnipeg, Manitoba, Canada. It also owns and operates a chain of retail stores under the Delta 9 Cannabis Store brand. It is focused on producing and selling cannabis oils, extracts, and derivative products.


GREY:DLTNF - Post by User

Comment by StonksOnlyGoUpon Mar 01, 2021 1:59pm
100 Views
Post# 32686749

RE:Delta 9 vs Cronos

RE:Delta 9 vs CronosAs Duedillengence pointed out it's not exactly a proper comparison, Chronos has a lot of speculation built into it's SP.  Is this really a failing of DN management?  Is John suddenly able to control overly excited investors and prevnt them from overbuying a company like Chronos?  I would say, that of the two companies, DN is a lot closer to a reasonable valuation than Chronos is. 

If anything changes in the US or legalization gets delayed there, those highly speculative buys are headed for a big fat correction, just like here in Canada when legalization failed to roll out in Ontario.


golfyeti wrote:

Delta 9

Last quarter revenues $14 Million. On verge of turning EBITDA positive.

Market cap $59 Million

Cronos

Last quarter revenues $17 Million.  Currently loosing $162 Million (last 12 months).

Market cap $5 Billion.  

84 TIMES OUR MARKET CAP !!!!   MARKET BELEIVES A COMPANY (CRONOS) MAKING THE SAME REVENUES BUT LOOSING $162 MILLION IS 84 TIMES MORE VALUABLE THAN MONEY-MAKIING DN !!!!

This is a unadulterated failure of DN management to promote our company to the investment community and secure a reasonable valuation for its shareholders!

84 TIMES !!!!!

 



<< Previous
Bullboard Posts
Next >>